BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Oliveira HC, Monteiro MC, Rossi SA, Pemán J, Ruiz-Gaitán A, Mendes-Giannini MJS, Mellado E, Zaragoza O. Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris. Front Cell Infect Microbiol 2019;9:83. [PMID: 31001487 DOI: 10.3389/fcimb.2019.00083] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Wall G, Lopez-Ribot JL. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity. Antimicrob Agents Chemother 2020;64:e00924-20. [PMID: 32660991 DOI: 10.1128/AAC.00924-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Gowri M, Jayashree B, Jeyakanthan J, Girija EK. Sertraline as a promising antifungal agent: inhibition of growth and biofilm of Candida auris with special focus on the mechanism of action in vitro. J Appl Microbiol 2020;128:426-37. [PMID: 31621139 DOI: 10.1111/jam.14490] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
3 Scorzoni L, Menezes RTD, Pereira TC, Oliveira PS, Ribeiro FDC, Santos ELDS, Fugisaki LR, Oliveira LDD, Amorim JBO. Antifungal and anti-biofilm effect of the calcium channel blocker verapamil on non-albicans Candida species. An Acad Bras Ciênc 2020;92:e20200703. [DOI: 10.1590/0001-3765202020200703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Chaves AFA, Xander P, Romera LMD, Fonseca FLA, Batista WL. What is the elephant in the room when considering new therapies for fungal diseases? Crit Rev Microbiol 2021;47:275-89. [PMID: 33513315 DOI: 10.1080/1040841X.2021.1876632] [Reference Citation Analysis]
5 Kean R, Ramage G. Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris. mSphere 2019;4:e00458-19. [PMID: 31366705 DOI: 10.1128/mSphere.00458-19] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 13.3] [Reference Citation Analysis]
6 Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp. Antimicrob Agents Chemother 2020;64:e01921-19. [PMID: 31988099 DOI: 10.1128/AAC.01921-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
7 de Moraes DC. Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review. J Mycol Med 2021;32:101232. [PMID: 34883404 DOI: 10.1016/j.mycmed.2021.101232] [Reference Citation Analysis]
8 de Moraes DC, Cardoso KM, Domingos LTS, do Carmo Freire Ribeiro Pinto M, Monteiro RQ, Ferreira-Pereira A. β-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain. Braz J Microbiol 2020;51:1051-60. [PMID: 32157667 DOI: 10.1007/s42770-020-00254-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
9 Scorzoni L, Fuchs BB, Junqueira JC, Mylonakis E. Current and promising pharmacotherapeutic options for candidiasis. Expert Opin Pharmacother 2021;22:867-87. [PMID: 33538201 DOI: 10.1080/14656566.2021.1873951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Bidaud A, Djenontin E, Botterel F, Chowdhary A, Dannaoui E. Colistin interacts synergistically with echinocandins against Candida auris. International Journal of Antimicrobial Agents 2020;55:105901. [DOI: 10.1016/j.ijantimicag.2020.105901] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
11 Gnat S, Łagowski D, Dyląg M, Jóźwiak G, Trościańczyk A, Nowakiewicz A. In Vitro Activity of Ebselen and Diphenyl Diselenide Alone and in Combination with Drugs against Trichophyton mentagrophytes Strains. Pharmaceutics 2022;14:1158. [DOI: 10.3390/pharmaceutics14061158] [Reference Citation Analysis]
12 Beattie SR, Krysan DJ. Antifungal drug screening: thinking outside the box to identify novel antifungal scaffolds. Curr Opin Microbiol 2020;57:1-6. [PMID: 32339892 DOI: 10.1016/j.mib.2020.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
13 Černáková L, Roudbary M, Brás S, Tafaj S, Rodrigues CF. Candida auris: A Quick Review on Identification, Current Treatments, and Challenges. Int J Mol Sci 2021;22:4470. [PMID: 33922907 DOI: 10.3390/ijms22094470] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
14 Billamboz M, Fatima Z, Hameed S, Jawhara S. Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris. Microorganisms 2021;9:634. [PMID: 33803604 DOI: 10.3390/microorganisms9030634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Kim JH, Cheng LW, Chan KL, Tam CC, Mahoney N, Friedman M, Shilman MM, Land KM. Antifungal Drug Repurposing. Antibiotics (Basel) 2020;9:E812. [PMID: 33203147 DOI: 10.3390/antibiotics9110812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
16 Wall G, Chen E, Hull MV, Lopez-Ribot JL. Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation. Front Cell Infect Microbiol 2020;10:597931. [PMID: 33324579 DOI: 10.3389/fcimb.2020.597931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
17 Liu J, Li Q, Wang C, Shao J, Wang T, Wu D, Ma K, Yan G, Yin D. Antifungal evaluation of traditional herbal monomers and their potential for inducing cell wall remodeling in Candida albicans and Candida auris. Biofouling 2020;36:319-31. [PMID: 32410461 DOI: 10.1080/08927014.2020.1759559] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
18 Cordisco E, Petenatti E, Svetaz L, Sortino M. Evaluation of the antifungal photodynamic activity of Thymophylla pentachaeta extracts against Candida albicans and its virulence factors. Phytomedicine 2021;90:153608. [PMID: 34148723 DOI: 10.1016/j.phymed.2021.153608] [Reference Citation Analysis]
19 Wall G, Herrera N, Lopez-Ribot JL. Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box. J Fungi (Basel) 2019;5:E92. [PMID: 31581540 DOI: 10.3390/jof5040092] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
20 Poester VR, Munhoz LS, Benelli JL, Melo AM, Al-Hatmi AMS, Larwood DJ, Martinez M, Stevens DA, Xavier MO. Initial Results of the International Efforts in Screening New Agents against Candida auris. J Fungi (Basel) 2022;8:771. [PMID: 35893139 DOI: 10.3390/jof8080771] [Reference Citation Analysis]
21 Nogueira CW, Barbosa NV, Rocha JBT. Toxicology and pharmacology of synthetic organoselenium compounds: an update. Arch Toxicol 2021;95:1179-226. [PMID: 33792762 DOI: 10.1007/s00204-021-03003-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
22 Jampilek J. Novel avenues for identification of new antifungal drugs and current challenges. Expert Opin Drug Discov 2022. [PMID: 35787715 DOI: 10.1080/17460441.2022.2097659] [Reference Citation Analysis]
23 Simm C, Weerasinghe H, Thomas DR, Harrison PF, Newton HJ, Beilharz TH, Traven A. Disruption of Iron Homeostasis and Mitochondrial Metabolism Are Promising Targets to Inhibit Candida auris. Microbiol Spectr 2022;:e0010022. [PMID: 35412372 DOI: 10.1128/spectrum.00100-22] [Reference Citation Analysis]
24 Benelli JL, Poester VR, Munhoz LS, Melo AM, Trápaga MR, Stevens DA, Xavier MO. Ebselen and diphenyl diselenide against fungal pathogens: A systematic review. Med Mycol 2021;59:409-21. [PMID: 33421963 DOI: 10.1093/mmy/myaa115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Cheng YS, Roma JS, Shen M, Mota Fernandes C, Tsang PS, Forbes HE, Boshoff H, Lazzarini C, Del Poeta M, Zheng W, Williamson PR. Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing Screen. Antimicrob Agents Chemother 2021;65:e01305-20. [PMID: 33468482 DOI: 10.1128/AAC.01305-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Aghaei Gharehbolagh S, Izadi A, Talebi M, Sadeghi F, Zarrinnia A, Zarei F, Darmiani K, Borman AM, Mahmoudi S. New weapons to fight a new enemy: A systematic review of drug combinations against the drug-resistant fungus Candida auris. Mycoses 2021. [PMID: 33774879 DOI: 10.1111/myc.13277] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Bidaud AL, Botterel F, Chowdhary A, Dannaoui E. In vitro antifungal combination of flucytosine with amphotericin B, voriconazole, or micafungin against Candida auris shows no antagonism. Antimicrob Agents Chemother 2019:AAC. [PMID: 31591129 DOI: 10.1128/AAC.01393-19] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
28 Wen W, Cao H, Huang Y, Tu J, Wan C, Wan J, Han X, Chen H, Liu J, Rao L, Su C, Peng C, Sheng C, Ren Y. Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of Candidiasis. J Med Chem 2022. [PMID: 35099959 DOI: 10.1021/acs.jmedchem.1c02102] [Reference Citation Analysis]
29 Arias LS, Butcher MC, Short B, McKloud E, Delaney C, Kean R, Monteiro DR, Williams C, Ramage G, Brown JL. Chitosan Ameliorates Candida auris Virulence in a Galleria mellonella Infection Model. Antimicrob Agents Chemother 2020;64:e00476-20. [PMID: 32482674 DOI: 10.1128/AAC.00476-20] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
30 Wall G, Lopez-Ribot JL. Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics (Basel) 2020;9:E445. [PMID: 32722455 DOI: 10.3390/antibiotics9080445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
31 de Oliveira HC, Joffe LS, Simon KS, Castelli RF, Reis FCG, Bryan AM, Borges BS, Medeiros LCS, Bocca AL, Del Poeta M, Rodrigues ML. Fenbendazole Controls In Vitro Growth, Virulence Potential, and Animal Infection in the Cryptococcus Model. Antimicrob Agents Chemother 2020;64:e00286-20. [PMID: 32253211 DOI: 10.1128/AAC.00286-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Cândido ES, Affonseca F, Cardoso MH, Franco OL. Echinocandins as Biotechnological Tools for Treating Candida auris Infections. J Fungi (Basel) 2020;6:E185. [PMID: 32971857 DOI: 10.3390/jof6030185] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Garcia-Bustos V, Cabanero-Navalon MD, Ruiz-Saurí A, Ruiz-Gaitán AC, Salavert M, Tormo MÁ, Pemán J. What Do We Know about Candida auris? State of the Art, Knowledge Gaps, and Future Directions. Microorganisms 2021;9:2177. [PMID: 34683498 DOI: 10.3390/microorganisms9102177] [Reference Citation Analysis]
34 Giacobbe DR, Magnasco L, Sepulcri C, Mikulska M, Koehler P, Cornely OA, Bassetti M. Recent advances and future perspectives in the pharmacological treatment of Candida auris infections. Expert Rev Clin Pharmacol 2021;:1-16. [PMID: 34176393 DOI: 10.1080/17512433.2021.1949285] [Reference Citation Analysis]